Intuitive Surgical (IUI1) Stock Forecast & Price Target

40 Followers

See the Price Targets and Ratings of:

All Analysts

Top Analysts

Premium

IUI1 Analyst Ratings

Strong Buy

15 Buy

2 Hold

0 Sell

Based on 17 analysts giving stock ratings to

Intuitive

Surgical

in the past 3 months

TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers in the past 3 months

IUI1 Stock 12 Month Forecast

Average Price Target

€435.74

▲(36.02% Upside)

Based on 17 Wall Street analysts offering 12 month price targets for Intuitive Surgical in the last 3 months. The average price target is €435.74 with a high forecast of €609.98 and a low forecast of €348.18. The average price target represents a 36.02% change from the last price of €320.35.

{"navigator":{"disabled":true},"exporting":{"enabled":false},"title":{"text":null},"chart":{"height":200,"style":{"fontFamily":"Roboto Flex, -apple-system, BlinkMacSystemFont, Segoe UI, Roboto, Helvetica, Arial, sans-serif, Apple Color Emoji, Segoe UI Emoji, Segoe UI Symbol","fontWeight":"400","color":"#5d5d5e"},"spacingTop":30,"spacingRight":60,"events":null},"yAxis":{"labels":{"style":{"color":"inherit"},"distance":6,"x":-6,"y":-6,"zIndex":1,"map_label_formatter":{"304":"€304","457":"€457","610":"€610","380.5":"€380.5","533.5":"€533.5"}},"plotLines":[{"color":"rgba(0,0,0,0)","value":609.97925895,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":-10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-bottom flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#199ca5\">High </span>\n\n  <span style=\"color:#199ca5\">€609.98</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":435.74187451999995,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":0,"text":"<div  class=\"positionrelative hoverZ3 triangleleft flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#828080\">Average </span>\n\n  <span style=\"color:#828080\">€435.74</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":348.17794197,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-top flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#912767\">Low </span>\n\n  <span style=\"color:#912767\">€348.18</span>\n  </div></div>","useHTML":true}}],"tickPositions":[304,380.5,457,533.5,610],"lineColor":"#dddddd","gridLineWidth":1,"gridLineColor":"#dddddd","lineWidth":1,"title":{"text":""}},"plotOptions":{"series":{"states":{"inactive":{"opacity":1}}},"line":{"animation":{"duration":0},"dataLabels":{"allowOverlap":true},"borderWidth":1,"marker":{"enabled":true,"fillColor":"#FFFFFF","radius":3,"lineWidth":2,"symbol":"circle","lineColor":"#828080"}}},"xAxis":{"labels":{"style":{"color":"inherit"},"rotation":0,"map_label_formatter":{"3":"Jan<br/>2026","6":"Apr<br/>2026","9":"Jul<br/>2026","12":"Oct<br/>2026","25":"Oct<br/>2027"}},"tickPositions":[3,6,9,12,25],"plotLines":[{"color":"#dddddd","width":1,"value":12},{"color":"#dddddd","width":1,"value":12}],"lineWidth":0,"gridLineWidth":1,"gridLineColor":"#dddddd","tickLength":0},"legend":{"symbolRadius":0,"symbolPadding":4,"symbolHeight":14,"borderWidth":0,"symbolWidth":14,"align":"left","verticalAlign":"bottom","enabled":false},"tooltip":{"backgroundColor":"rgba(0,0,0,0)","useHTML":true,"borderWidth":0,"borderColor":"rgba(0,0,0,0)","padding":0,"shadow":null,"headerFormat":"","footerFormat":"","pointFormat":"<div class=\"flexccc lineHeight2 bgwhite shadow2 px3 py3 radiismall fonth10_semibold\">\n                <span class=\"colorgray-3 mb4\">{point.date:%b %d ,%Y}</span>\n                <span>Analyst Consensus</span>\n                {point.info}\n          </div>\n           </div>"},"credits":{"enabled":false},"accessibility":{"description":""},"responsive":{"rules":[{"chartOptions":{"chart":{"spacing":[0,0,0,0],"margin":[30,60,40,5]},"xAxis":{"tickPositions":[3,12,25.25]},"yAxis":{"labels":{"enabled":false}},"title":{"text":null},"subtitle":{"text":null}},"condition":{"maxWidth":500}}]},"series":[{"lineWidth":2,"dashStyle":"ShortDash","name":"High","type":"line","color":"#199ca5","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,360.1,379.32148145769236,398.54296291538463,417.76444437307697,436.98592583076925,456.2074072884616,475.4288887461539,494.6503702038462,513.8718516615385,533.0933331192308,552.3148145769231,571.5362960346154,590.7577774923077,{"y":609.97925895,"marker":{"fillColor":"#199ca5","lineColor":"#199ca5","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Average","type":"line","color":"#828080","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,360.1,365.9186057323077,371.73721146461537,377.5558171969231,383.3744229292308,389.19302866153845,395.0116343938461,400.83024012615385,406.6488458584615,412.4674515907692,418.2860573230769,424.10466305538455,429.9232687876923,{"y":435.74187451999995,"marker":{"fillColor":"#828080","lineColor":"#828080","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Low","type":"line","color":"#912767","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,360.1,359.18291861307694,358.26583722615385,357.34875583923076,356.43167445230773,355.51459306538464,354.59751167846156,353.68043029153847,352.7633489046154,351.8462675176923,350.92918613076927,350.0121047438462,349.0950233569231,{"y":348.17794197,"marker":{"fillColor":"#912767","lineColor":"#912767","enabled":true,"symbol":"circle"}}]},{"type":"line","data":[{"y":369.85,"date":1759276800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 33,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 5, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":462.35,"date":1761955200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 32,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 6, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":491,"date":1764547200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 30,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 7, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":489.2,"date":1767225600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 29,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 7, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":423.8,"date":1769904000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 32,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 7, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":423.4,"date":1772323200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 29,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 8, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":402.25,"date":1775001600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 26,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 7, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":386.8,"date":1777593600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 27,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 7, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":361.25,"date":1780272000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 28,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 5, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":355.7,"date":1782864000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 40,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 4, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":305,"date":1785542400000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 41,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 3, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":318.1,"date":1788220800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 40,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 3, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":360.1,"date":1790812800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 19,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"fillColor":"black","lineColor":"black","enabled":true,"symbol":"circle"}},null,null,null,null,null,null,null,null,null,null,null,null],"color":"#0666a7"}]}

Highest Price Target€609.98

Average Price Target€435.74

Lowest Price Target€348.18

The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.

Detailed List of Analyst Forecasts

Joshua Buchalter

TD Cowen

€431.88

Buy

34.82%

Upside

Reiterated

10/19/26

Anthony Petrone

Mizuho Securities

€356.19→€369.55

Hold

15.36%

Upside

Assigned

10/13/26

Intuitive Surgical price target raised to $415 from $400 at MizuhoIntuitive Surgical price target raised to $415 from $400 at Mizuho

Patrick Wood

UBS

€445.24

Buy

38.99%

Upside

Reiterated

10/13/26

Intuitive Surgical: Buy Rating Reiterated on Long-Term Robotic Growth Runway; Price Target Maintained at $500

Mike Kratky

Leerink Partners

€404.28→€421.2

Buy

31.48%

Upside

Assigned

10/12/26

Leerink Partners Keeps Their Buy Rating on Intuitive Surgical (ISRG)

Ryan Zimmerman

BTIG

€417.64→€404.28

Buy

26.20%

Upside

Reiterated

10/12/26

Intuitive Surgical price target lowered to $454 from $469 at BTIGIntuitive Surgical price target lowered to $454 from $469 at BTIG

Adam Maeder

Piper Sandler

€418.53

Buy

30.65%

Upside

Reiterated

10/07/26

Intuitive Surgical (ISRG) Gets a Buy from Piper Sandler

Christopher Pasquale

Barclays

€431.88

Buy

34.82%

Upside

Initiated

10/07/26

Barclays Sticks to Their Buy Rating for Intuitive Surgical (ISRG)

Joanne Wuensch

Citi

€445.24

Buy

38.99%

Upside

Reiterated

10/05/26

Intuitive Surgical (ISRG) Gets a Buy from Citi

Kendall Au

RBC Capital

€512.03

Buy

59.83%

Upside

Reiterated

10/01/26

RBC Capital Reaffirms Their Buy Rating on Intuitive Surgical (ISRG)

Travis Steed

Bank of America Securities

€418.53

Buy

30.65%

Upside

Reiterated

09/21/26

Analysts Are Bullish on Top Healthcare Stocks: Alcon (ALC), Intuitive Surgical (ISRG)

Vik Chopra

BMO Capital

―

Buy

―

Reiterated

08/28/26

Analysts Offer Insights on Healthcare Companies: Impedimed Limited (Other OTC: IPDQF) and Intuitive Surgical (NASDAQ: ISRG)

Suraj Kalia

Oppenheimer

€445.24

Buy

38.99%

Upside

Upgraded

08/12/26

Analysts Have Conflicting Sentiments on These Healthcare Companies: Intuitive Surgical (NASDAQ: ISRG), Legend Biotech (NASDAQ: LEGN) and Mineralys Therapeutics, Inc. (NASDAQ: MLYS)

Lee Hambright

Bernstein

€609.98

Buy

90.41%

Upside

Reiterated

08/11/26

Intuitive Surgical: Buy Rating Reiterated as New GI Platform Progress Supports Growth; $685 Price Target Maintained

Helen Fang

HSBC

€348.18

Hold

8.69%

Upside

Downgraded

07/30/26

Intuitive Surgical downgraded to Hold from Buy at HSBCIntuitive Surgical downgraded to Hold from Buy at HSBC

Larry Biegelsen

Wells Fargo

€433.66

Buy

35.37%

Upside

Reiterated

07/23/26

Wells Fargo Reaffirms Their Buy Rating on Intuitive Surgical (ISRG)

Analyst Type

Any

Human Analysts

Ranks

Any

Analyst Rating

Any

Upside/ Downside

Any

Action

Any

Joshua Buchalter

TD Cowen

€431.88

Buy

34.82%

Upside

Reiterated

10/19/26

Anthony Petrone

Mizuho Securities

€356.19→€369.55

Hold

15.36%

Upside

Assigned

10/13/26

Intuitive Surgical price target raised to $415 from $400 at MizuhoIntuitive Surgical price target raised to $415 from $400 at Mizuho

Patrick Wood

UBS

€445.24

Buy

38.99%

Upside

Reiterated

10/13/26

Intuitive Surgical: Buy Rating Reiterated on Long-Term Robotic Growth Runway; Price Target Maintained at $500

Mike Kratky

Leerink Partners

€404.28→€421.2

Buy

31.48%

Upside

Assigned

10/12/26

Leerink Partners Keeps Their Buy Rating on Intuitive Surgical (ISRG)

Ryan Zimmerman

BTIG

€417.64→€404.28

Buy

26.20%

Upside

Reiterated

10/12/26

Intuitive Surgical price target lowered to $454 from $469 at BTIGIntuitive Surgical price target lowered to $454 from $469 at BTIG

Adam Maeder

Piper Sandler

€418.53

Buy

30.65%

Upside

Reiterated

10/07/26

Intuitive Surgical (ISRG) Gets a Buy from Piper Sandler

Christopher Pasquale

Barclays

€431.88

Buy

34.82%

Upside

Initiated

10/07/26

Barclays Sticks to Their Buy Rating for Intuitive Surgical (ISRG)

Joanne Wuensch

Citi

€445.24

Buy

38.99%

Upside

Reiterated

10/05/26

Intuitive Surgical (ISRG) Gets a Buy from Citi

Kendall Au

RBC Capital

€512.03

Buy

59.83%

Upside

Reiterated

10/01/26

RBC Capital Reaffirms Their Buy Rating on Intuitive Surgical (ISRG)

Travis Steed

Bank of America Securities

€418.53

Buy

30.65%

Upside

Reiterated

09/21/26

Analysts Are Bullish on Top Healthcare Stocks: Alcon (ALC), Intuitive Surgical (ISRG)

Vik Chopra

BMO Capital

―

Buy

―

Reiterated

08/28/26

Analysts Offer Insights on Healthcare Companies: Impedimed Limited (Other OTC: IPDQF) and Intuitive Surgical (NASDAQ: ISRG)

Suraj Kalia

Oppenheimer

€445.24

Buy

38.99%

Upside

Upgraded

08/12/26

Analysts Have Conflicting Sentiments on These Healthcare Companies: Intuitive Surgical (NASDAQ: ISRG), Legend Biotech (NASDAQ: LEGN) and Mineralys Therapeutics, Inc. (NASDAQ: MLYS)

Lee Hambright

Bernstein

€609.98

Buy

90.41%

Upside

Reiterated

08/11/26

Intuitive Surgical: Buy Rating Reiterated as New GI Platform Progress Supports Growth; $685 Price Target Maintained

Helen Fang

HSBC

€348.18

Hold

8.69%

Upside

Downgraded

07/30/26

Intuitive Surgical downgraded to Hold from Buy at HSBCIntuitive Surgical downgraded to Hold from Buy at HSBC

Larry Biegelsen

Wells Fargo

€433.66

Buy

35.37%

Upside

Reiterated

07/23/26

Wells Fargo Reaffirms Their Buy Rating on Intuitive Surgical (ISRG)

Stocks with the Highest Top Analyst Consensus in the Healthcare Sector

KNSAKiniksa Pharmaceuticals

OMCLOmnicell

AXGNAxoGen

ONCBeOne Medicines

AHCOAdaptHealth

Find stocks in the Healthcare sector that are highly recommended by Top Performing Analysts.

Best Analysts Covering Intuitive Surgical

3 Months

Mike KratkyLeerink Partners

Success Rate

12/15 ratings generated profit

Average Return

+13.03%

Copying Mike Kratky's trades and holding each position for 3 Months would result in 80.00% of your transactions generating a profit, with an average return of +13.03% per trade.

1 Year

Joanne WuenschCiti

Success Rate

23/28 ratings generated profit

Average Return

+20.66%

Copying Joanne Wuensch's trades and holding each position for 1 Year would result in 82.14% of your transactions generating a profit, with an average return of +20.66% per trade.

2 Years

Joanne WuenschCiti

Success Rate

25/28 ratings generated profit

Average Return

+38.46%

Copying Joanne Wuensch's trades and holding each position for 2 Years would result in 89.29% of your transactions generating a profit, with an average return of +38.46% per trade.

The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.

IUI1 Analyst Recommendation Trends

Rating

Jun 26

Jul 26

Aug 26

Sep 26

Oct 26

Strong Buy

Buy

Hold

Sell

Strong Sell

total

In the current month, IUI1 has received 19 Buy Ratings, 1 Hold Ratings, and 0 Sell Ratings. IUI1 average Analyst price target in the past 3 months is 435.74.

Each month's total comprises the sum of three months' worth of ratings.

IUI1 Financial Forecast

IUI1 Earnings Forecast

Next quarter’s earnings estimate for IUI1 is €2.36 with a range of €2.25 to €2.46. The previous quarter’s EPS was €2.49. IUI1 beat its EPS estimate ― of the time in the past 12 months, while its overall industry beat the EPS estimate 57.80% of the time in the same period. In the last calendar year IUI1 has Performed in-line its overall industry.

IUI1 Sales Forecast

Next quarter’s sales forecast for IUI1 is €2.59B with a range of €2.54B to €2.66B. The previous quarter’s sales results were €2.58B. IUI1 beat its sales estimates ― of the time in past 12 months, while its overall industry beat sales estimates 50.04% of the time in the same period. In the last calendar year IUI1 has Performed in-line its overall industry.

IUI1 Stock Forecast FAQ

What is DE:IUI1’s average 12-month price target, according to analysts?

Based on analyst ratings, Intuitive Surgical’s 12-month average price target is 435.74.

What is DE:IUI1’s upside potential, based on the analysts’ average price target?

Intuitive Surgical has 36.02% upside potential, based on the analysts’ average price target.

Can I see which stocks the top-ranking analysts are rating?

Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.

How can I follow the stock ratings of top Wall Street analysts?

Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.

Is Intuitive Surgical a Buy, Sell or Hold?

Intuitive Surgical has a consensus rating of Strong Buy, which is based on 15 buy ratings, 2 hold ratings and 0 sell ratings.

What is Intuitive Surgical’s share price target?

The average share price target for Intuitive Surgical is 435.74. This is based on 17 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
The highest analyst share price target is €609.98 ,and the lowest forecast is €348.18. The average share price target represents 36.02% Increase from the current price of €320.35.

What do analysts say about Intuitive Surgical?

Intuitive Surgical’s analyst rating consensus is a Strong Buy. This is based on the ratings of 17 Wall Streets Analysts.

How can I buy shares of Intuitive Surgical?

To buy shares of DE:IUI1, you can open a brokerage account. See exclusive account opening deals on our Best Online Brokers page.

Intuitive Surgical (IUI1) Stock Forecast & Price Target

IUI1 Analyst Ratings

IUI1 Stock 12 Month Forecast

Average Price Target

Detailed List of Analyst Forecasts​

Best Analysts Covering Intuitive Surgical

IUI1 Analyst Recommendation Trends

IUI1 Financial Forecast

IUI1 Earnings Forecast

IUI1 Sales Forecast

IUI1 Stock Forecast FAQ

Detailed List of Analyst Forecasts